
A 49% premium can still be a loss.
That sounds like bad math. It is actually how take-privates get done.
Thoma Bravo offered $20.25 a share for Accelerant. The board can call that a 49% premium to Wednesday's close. An investor who bought the IPO thirteen months ago sees a 3.6% markdown.
Thoma Bravo sees neither.
It sees a price that only works if private ownership makes the business worth more.
Weave is the same paradox at a more extreme scale: a 34% premium to the last close and 69.2% below its 2021 IPO price.
One price. Three completely different stories.
The seller sees certainty. The legacy holder remembers the old promise. The buyer underwrites a future that does not exist yet.
That is the quiet trick inside every take-private. The seller gets to choose the reference point. The buyer has to change the business.
Accelerant enters that test with exchange written premium up 23% and a 30.6% adjusted EBITDA margin, but sharply lower net revenue retention. Weave enters it growing 15.5%, producing free cash flow, and still reporting a GAAP operating loss.
The announcement tells us what changed hands.
The operating plan will decide who was right.
In this issue:
The Tape: Seven current deals, each reduced to its operating mechanism.
The One Thing: Why the seller needs a premium and the buyer needs a discount.
The Operating Edge: The three columns every take-private memo should contain.
From the Deal File: ATG and the business that remembers.
Get the private-equity tape and the operating question underneath it every Friday.
The Tape
Accelerant: the IPO that lasted thirteen months
Thoma Bravo agreed to acquire Accelerant for more than $4 billion, or $20.25 per share. Public shareholders get cash. Altamont and the founders intend to keep equity alongside the new control owner.
That ownership split is more revealing than the 49% premium.
Accelerant reported a strong second quarter: exchange written premium rose 23% to $1.32 billion, and adjusted EBITDA reached $93.1 million at a 30.6% margin. But net revenue retention fell to 111% from 151% a year earlier.
Thoma Bravo is buying growth, margin, and a warning label.
The upside case is a risk exchange whose data, member network, and capital relationships become more valuable as they scale. The downside case is that headline premium growth masks weaker economics inside the existing book.
The rollover says the old owners still want the next chapter. It does not guarantee the chapter will be good.
Weave: the growth story learned to produce cash
Francisco Partners agreed to acquire Weave for roughly $650 million, or $7.40 per share.
The 34% premium sounds generous until it meets the $24 IPO price. The more useful comparison is operating.
Second-quarter revenue rose 15.5% to $67.5 million. Free cash flow nearly doubled to $8.7 million. Payments grew about twice as fast as revenue, and the company added more customer locations than in any prior quarter. GAAP operating loss was still $4.4 million.
This is not a rescue of a stalled software company. It is a bet that a vertical platform crossing from growth into cash generation will compound better away from the public market.
The moat also has to move. As AI makes reception and scheduling features easier to build, Weave's advantage must come from workflow integration, payments, distribution, and the data created across nearly 40,000 customer locations, not from an AI label every competitor can copy.
CheckedUp: the last screen before the prescription
Rockbridge agreed to sell CheckedUp to Providence, with Varsity Healthcare joining as a minority investor and management continuing to lead the company. Rockbridge backed CheckedUp in 2021 and combined it with Health Media Network in 2022.
Most media businesses fight for attention before the audience has context. CheckedUp reaches patients and physicians inside the clinical decision loop.
That location changes the economics. The closer media sits to a real decision, the less mass reach it needs to matter. But proximity only remains valuable while the network is useful to physicians and patients. Lose trust, and premium inventory becomes a television nobody wants in the room.
Certified Group: 31 labs are not scale. They are latency.
Mérieux NutriSciences agreed to acquire Warburg Pincus-backed Certified Group, which generates about $300 million of revenue across 31 North American laboratories.
The product is not simply more testing capacity. It is confidence delivered on a deadline.
A denser lab network can shorten sample travel, place specialized tests closer to customers, and create backup capacity when one site is constrained. That turns physical distance into an operating variable.
The risk is the mirror image. If methods, handoffs, and quality systems vary across the network, 31 laboratories create 31 ways to disappoint the same customer.
FireBird: Continental bought 307 future decisions
Continental Resources agreed to acquire Quantum-backed FireBird Energy II, adding 147,000 net resource acres, about 32,000 barrels of oil equivalent per day of current production, and 307 gross operated drilling locations.
The production enters the model today. The inventory preserves choices for tomorrow.
Each undrilled location is an option on commodity prices, infrastructure, timing, and capital. A neighboring strategic owner can often exercise those options more efficiently through shared systems and coordinated development.
Today's barrel earns today's price. The undeveloped acre lets the owner wait for a better decision.
Graphwise: AI makes answers cheap. It may make evidence expensive.
Oakley acquired a majority stake in Graphwise, which says it serves more than 200 enterprise customers with knowledge-graph and semantic technology.
The obvious AI thesis is that models get smarter and software gets easier to build.
The less obvious thesis is that abundant answers increase the value of provenance. When a model can trigger a financial, medical, or operational decision, the enterprise needs to know what it used, how the concepts connect, and whether the source deserves trust.
Graphwise is a bet that intelligence becomes abundant before reliable context does.
Blackford: roll-ups are maps disguised as spreadsheets
Blackford's Security Fire Solutions acquired Industrial Electronic Systems, its second add-on since the platform was established in December 2024.
Fire and life-safety services combine code-driven demand, an installed base, and recurring inspection and monitoring work. The spreadsheet says the platform gets larger. The map decides whether it gets better.
If the acquisition reduces windshield time, raises technician utilization, improves purchasing, and puts more customers within each route, geography becomes an operating advantage.
If it does not, the platform is merely a collection with a consolidated logo.
The One Thing
The price of agreement
I learned the strangest thing I know about deal prices while working at J.C. Penney.
I was there during the 2012 “Fair and Square” rollout. I did not discover this story years later in a business-school case. I watched it unfold from inside the company.
The idea was not stupid. It was almost irresistible.
Ron Johnson had led Apple's retail strategy and helped launch Target's design initiative. He put $50 million of his own money into a seven-and-a-half-year J.C. Penney warrant. The company would replace its exhausting cycle of coupons and promotions with three simpler prices: everyday, month-long, and best price.
No games. No fake urgency. Treat customers as the company wanted to be treated: fair and square.

The square-era J.C. Penney storefront in Frisco, Texas, January 2013. Photo by Jonesdr77 via Wikimedia Commons, CC BY-SA 3.0. Uncropped.
Then comparable-store sales fell 25.2% in one year.
Pricing was not the only thing J.C. Penney changed, and the failure cannot be reduced to “customers love coupons.” The deeper lesson was more useful.
A rational strategy can fail when it removes the customer's way of recognizing value.
A coupon did more than lower the price. It created a reference point, a small feeling of victory, and a reason to act now. Fair and Square tried to remove the theater from pricing. It also removed part of the signal customers used to decide whether they were getting a deal.
I had a front-row seat to the gap between the price a company explains and the value a customer feels.
M&A headlines use the same machinery.
“Price is what you pay; value is what you get.”
A takeover premium is neither.
It is the distance between two prices.
That distance must tell three different stories:
The seller's story: the offer is a premium to the unaffected share price, making certainty easier to defend.
The legacy holder's story: the offer is a gain or loss against the price at which expectations were originally sold.
The buyer's story: the offer is a discount to the value the business can have if the operating plan works.
The first two stories are visible. The third is the underwriting.

Here is where the analogy stops and the underwriting begins.
J.C. Penney tried to change the way customers perceived price without preserving the behavior that made the old model work. A take-private can make the mirror-image mistake: treating a better entry price as proof of a better business.
It is not.
A reference point can win the vote. It cannot create the return.
Accelerant: when does a network become a flywheel?
Accelerant's headline numbers pull in opposite directions.
Exchange written premium grew 23%. Adjusted EBITDA grew 46%. The network reached 314 members, up from 248 a year earlier. Third-party insurers supplied 47% of exchange written premium, up from 27%.
But net revenue retention fell from 151% to 111%. Accelerant retained 13% of exchange premium, up from 6%. Its gross loss ratio moved from 50.5% to 52.0%.
The business is larger. The question is whether it is becoming more self-reinforcing.
The upside case looks like this: more specialist underwriters bring more differentiated risk; more risk-capital partners bring more capacity; more activity produces better data; better matching and underwriting attract more of both. Each participant makes the exchange more useful to the next one.
That is a flywheel.
The downside is a network that grows by adding nodes while the economics inside each node weaken. New members can obscure slower expansion from existing ones. More premium can require more retained risk. A few poor underwriting years can make outside capital cautious precisely when the exchange needs it most.
Thoma Bravo is not merely betting that Accelerant will write more premium. It needs the network to become more valuable without the balance sheet absorbing proportionally more risk.
The early proof will not be the 49% premium. It will be net revenue retention stabilizing, third-party participation continuing to rise, member growth holding, and fee-based earnings compounding faster than retained exposure.
Altamont and Accelerant's founders intend to keep equity in the private company. That puts part of the old ownership behind the new plan. It is alignment, not proof.
Weave: can the front desk become the operating system?
Weave is a different bet.
Revenue grew 15.5% in the second quarter. Free cash flow nearly doubled to $8.7 million. Payments grew roughly twice as fast as revenue, and the company added more customer locations than in any prior quarter. More than 40,000 locations now use the platform.
Those numbers suggest the original communications product is becoming a wedge into something larger.
A patient call can lead to an appointment. The appointment can trigger insurance verification. The visit can create a balance. The balance can become a payment. A point solution touches one step. An operating system closes the loop.
That is Francisco Partners' opportunity: turn Weave from software a practice uses into work the practice no longer has to coordinate itself.
Payments matter because they monetize the workflow. Integrations matter because they remove duplicate entry. AI matters only if it completes more of the job.
The risk is that AI makes the visible features easier to copy. If every practice-management vendor can answer a phone, send a text, and schedule an appointment, “AI-powered” becomes packaging. Weave's moat then has to come from authorized integrations, distribution, workflow depth, and the ability to carry a task all the way to collected revenue.
The early proof will be location growth, payments adoption, multi-location expansion, and free-cash-flow conversion. If those improve together, Weave is deepening its position. If AI usage rises while payments and retention do not, the company may simply be shipping popular features into a crowded market.
At signing, no Weave executive had agreed to roll equity into the surviving company. That is not a verdict on the deal, but it removes one alignment signal that is present in Accelerant.
Two deals. Two discounts that still have to be earned.
Accelerant's discount exists only if network growth becomes more durable and capital efficient.
Weave's discount exists only if workflow and payments deepen faster than AI commoditizes the surface features.
Neither proposition is proven by comparing the offer with yesterday's close or an old IPO price. Those comparisons describe the negotiation. They do not describe the value-creation plan.
The best take-private thesis should fit into one sentence with a measurable verb:
Accelerant: grow third-party capital and member value without weakening retention or absorbing proportionally more risk.
Weave: turn patient communications into a closed-loop workflow that ends in collected revenue.
If the sentence cannot be written that clearly, the buyer may not have found a discount. It may have found a lower number.
That is the paradox at the center of every take-private:
A premium can make a deal easy to vote for and hard to earn a return on.
A discount can make an investment look tragic and the buyout still be expensive.
J.C. Penney could explain why Fair and Square was rational. Customers still had to feel more value.
A sponsor can explain why the entry price is attractive. The business still has to produce more value.
The premium is the price of agreement.
The buyer's discount is earned after closing.
J.C. Penney's 2012 pricing strategy · J.C. Penney's 2012 results · Ron Johnson background and warrant · Accelerant transaction · Accelerant Q2 results · Weave transaction · Weave Q2 results · Berkshire Hathaway 2008 shareholder letter · Storefront image and license
Worth sharing? Send this analysis to one person who would argue with it.
From the Deal File
ATG and the business that remembers

Most people think a theater company sells shows.
That is the most perishable part of the business.
Every night begins with a fresh clock. When the curtain rises, each empty seat becomes worth zero. Providence spent thirteen years surrounding that unstable product with assets that persist: scarce venues, ticketing, production relationships, hospitality, and audience data.
MARI is now acquiring a company with 70 venues and nearly 19 million annual theatergoers at a reported valuation of roughly $6 billion including debt.
The investment case is not that the next show will be a hit. It is that the system makes every hit worth more and every miss less damaging.
The show changes.
The business remembers.
The Operating Edge
Put the buyer's discount next to the seller's premium
Every take-private memo should force two sentences onto the same page:
Seller case: This price is attractive relative to the credible alternatives because…
Buyer case: This price is a discount to plan value because we can change…
Then show three columns:
Price of certainty. Premium to the unaffected price; value of cash today; execution risk removed for the seller.
Price of the business today. Normalized revenue, retention, margin, free cash flow, leverage, and reinvestment needs.
Price of the plan. The specific operating changes that create the buyer's discount after accounting for time, risk, and the cost of capital.
The third column is where weak theses hide.
“We can hold it longer” is not a value-creation plan. Time only becomes an advantage when it permits an action the current ownership model could not take.
For Accelerant, track member economics and net revenue retention, not just premium volume. For Weave, track location growth, payments attach, free-cash-flow conversion, and whether AI expands workflow ownership or merely becomes another feature.
If the buyer's discount cannot be explained without the words multiple expansion, the seller may be the only party with a complete story.
Number of the Week
13 months
The time between Accelerant's July 2025 IPO and its agreement to return to private ownership.
Long enough for the public reference point to break.
Far too short to treat the original expectations as ancient history.
The Monday Poll
Which buyer thesis would you rather underwrite?
The Monday Question
Which operating change creates the buyer's discount? Can the team name it without saying more time or multiple expansion?
Reply and tell me what I missed. The best answers may shape next week's issue.
Nick
Founder, The Multiple
Sources
Accelerant transaction · Accelerant Q2 · Accelerant IPO · Weave transaction · Weave Q2 · Weave IPO · CheckedUp · Certified Group · FireBird · Graphwise · Blackford · J.C. Penney strategy · J.C. Penney results · Berkshire letter
The Multiple is an independent publication about private equity, exits, and the operating work behind enterprise value. Analysis is for informational purposes only.
Useful enough to share?
Private equity is a small world. The Multiple grows one smart reader at a time.
Send this issue to an investor, operator, executive, or adviser who would use it.
New here? Get The Weekly Multiple every Friday.